These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Rational Design of a Highly Potent and Selective Peptide Inhibitor of PACE4 by Salt Bridge Interaction with D160 at Position P3. Dianati V; Shamloo A; Kwiatkowska A; Desjardins R; Soldera A; Day R; Dory YL ChemMedChem; 2017 Aug; 12(15):1169-1172. PubMed ID: 28722823 [TBL] [Abstract][Full Text] [Related]
34. Structure of the unliganded form of the proprotein convertase furin suggests activation by a substrate-induced mechanism. Dahms SO; Arciniega M; Steinmetzer T; Huber R; Than ME Proc Natl Acad Sci U S A; 2016 Oct; 113(40):11196-11201. PubMed ID: 27647913 [TBL] [Abstract][Full Text] [Related]
35. Preparations of psi-peptide bond and peptide-aldehyde inhibitors of atrial granule serine proteinase, a candidate processing enzyme of pro-atrial natriuretic factor. Damodaran A; Harris RB J Protein Chem; 1995 Aug; 14(6):431-40. PubMed ID: 8593183 [TBL] [Abstract][Full Text] [Related]
36. Phosphono Bisbenzguanidines as Irreversible Dipeptidomimetic Inhibitors and Activity-Based Probes of Matriptase-2. Häußler D; Mangold M; Furtmann N; Braune A; Blaut M; Bajorath J; Stirnberg M; Gütschow M Chemistry; 2016 Jun; 22(25):8525-35. PubMed ID: 27214780 [TBL] [Abstract][Full Text] [Related]
37. Blockade of furin activity and furin-induced tumor cells malignant phenotypes by the chemically synthesized human furin prodomain. Basak A; Chen A; Scamuffa N; Mohottalage D; Basak S; Khatib AM Curr Med Chem; 2010; 17(21):2214-21. PubMed ID: 20459383 [TBL] [Abstract][Full Text] [Related]
38. Cyanopeptide analogues: new lead structures for the design and synthesis of new thrombin inhibitors. Radau G; Stürzebecher J Pharmazie; 2002 Nov; 57(11):729-32. PubMed ID: 12611274 [TBL] [Abstract][Full Text] [Related]